A. McCune

发表

Molecular targets in the treatment of alcoholic hepatitis.

A. Dhanda, C. McCune, P. Collins, 2012, World journal of gastroenterology.

In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA

S. Atkinson, M. Thursz, P. Richardson, 2017, Gastroenterology.

Mental Imagery to Reduce Alcohol-related harm in patients with alcohol dependence and alcohol-related liver damaGE: the MIRAGE pilot trial protocol

L. Cocking, V. Allgar, A. Hawton, 2022, BMJ Open.

Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial

P. Roderick, M. Thursz, P. Richardson, 2013, Trials.

Penetrance in hereditary hemochromatosis.

M. Worwood, A. Mccune, A. McCune, 2003, Blood.

Hereditary haemochromatosis: only 1% of adult HFE C282Y homozygotes in South Wales have a clinical diagnosis of iron overload

M. Worwood, A. May, Sara L Hayes, 2002, Human Genetics.

Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study

R. Jalan, D. Valla, M. Stepanova, 2018, Quality of Life Research.

Baseline neutrophil‐to‐lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis

P. Hayes, S. Atkinson, M. Thursz, 2019, Alimentary pharmacology & therapeutics.

Prednisolone or pentoxifylline for alcoholic hepatitis.

M. Thursz, P. Richardson, J. O'grady, 2015, The New England journal of medicine.